Abstract:Transforming growth factor-beta (TGF-beta) elicits cellular effects by activating specific Smad proteins that control the transcription of target genes. Whereas there is growing evidence that there are TGF-beta type I receptor-initiated intracellular pathways that are distinct from the pivotal Smad pathway, their physiological importance in TGF-beta signaling is not well understood. Therefore, we generated TGF-beta type I receptors (also termed ALK5s) with mutations in the L45 loop of the kinase domain, termed ALK5(D266A) and ALK5(3A). These mutants showed retained kinase activity but were unable to activate Smads. Characterization of their signaling properties revealed that the two L45 loop mutants did not mediate Smad-dependent transcriptional responses, TGF-beta-induced growth inhibition, and fibronectin and plasminogen activator-1 production in R4-2 mink lung epithelial cells lacking functional ALK5 protein. Mutation in the L45 loop region did not affect the binding of inhibitory Smads but did abrogate the weak binding of X-linked inhibitor of apoptosis protein and Disabled-2 to ALK5. This suggests that the L45 loop in the kinase domain is important for docking of other binding proteins. Interestingly, JNK MAP kinase activity was found to be activated by the ALK5(3A) mutant in various cell types. In addition, TGF-beta-induced inhibition of cyclin D1 expression and stimulation of PMEPA1 (androgen-regulated prostatic mRNA) expression were found to occur, albeit weakly, in an Smad-independent manner in normal murine mammary gland cells. However, the TGF-beta-induced epithelial to mesenchymal transdifferentiation was found to require an intact L45 loop and is likely to be dependent on the Smad pathways.

Identification Of The Gene Transcription And Apoptosis Mediated By Tgf-Beta-Smad2/3-Smad4 Signaling

Axin and GSK3- Control Smad3 Protein Stability and Modulate TGF- Signaling.

Posttranslational Regulation of Smads

Signaling of Transforming Growth Factor‐β Family Members Through Smad Proteins

TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.

Functional Characterization of Transforming Growth Factor Β Signaling in Smad2- and Smad3-deficient Fibroblasts*

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-beta signaling.

The Tumor Suppressor Smad4/Dpc4 and Transcriptional Adaptor Cbp/P300 Are Coactivators for Smad3 in Tgf-Beta-Induced Transcriptional Activation

Ligand-dependent ubiquitination of Smad3 is regulated by casein kinase 1 gamma 2, an inhibitor of TGF-β signaling

Post‐translational Regulation of TGF‐β Receptor and Smad Signaling

Post-translational regulation of TGF-β receptor and Smad signaling.

Smad Protein Mediated Transforming Growth Factor Β1 Induction of Apoptosis in the MDPC-23 Odontoblast-Like Cell Line

Using RNA interference to identify the different roles of SMAD2 and SMAD3 in NIH/3T3 fibroblast cells.

Study of Mechanism of Apoptotic Signal Transduction in Human Hepatic Carcinoma Cell Lines Induced by TGF-β1

TGF-β signaling by Smad proteins

Smad4 Participates in the TGF--#beta#1--mediated ERK/MAPK Signaling Pathway

Smad2 and Smad3 Have Differential Sensitivity in Relaying TGFβ Signaling and Inversely Regulate Early Lineage Specification

Differential regulation of TGF-β signaling through Smad2, Smad3 and Smad4

Elucidation of Smad Requirement in Transforming Growth Factor-β Type I Receptor-induced Responses

Apoptosis of Human Hepatoma Cell Lines Induced by Transforming Growth Factor Beta 1 (Tgf-Beta1) Correlates with P53 and Smad4 Activation.

Smad3 and Smad4 Cooperate with C-Jun/c-fos to Mediate TGF-β-induced Transcription